hoʻohui2
He aha nā meaʻai i ʻōlelo ʻia no ka maʻi maʻi?
he nīnau maʻamau. ʻO nā Plan Nutrition Personalized he mau meaʻai a me nā mea hoʻohui i hoʻopilikino ʻia i kahi hōʻailona maʻi maʻi, genes, nā lāʻau lapaʻau a me nā kūlana ola.

Nā Pōmaikaʻi Lapaʻau o Indole-3-Carbinol (I3C) i ka maʻi ʻaʻai

Jul 6, 2021

4.7
(67)
Kuhi manawa heluhelu: 11 mau minuke
Home » Blogs » Nā Pōmaikaʻi Lapaʻau o Indole-3-Carbinol (I3C) i ka maʻi ʻaʻai

o ka Naauao

ʻO kahi noiʻi hou i hana ʻia ma 2018 i manaʻo ʻia e loaʻa paha i ka indole-3-carbinol (I3C) nā pōmaikaʻi ma ke ʻano he mālama mālama ʻana i nā maʻi maʻi maʻi ovarian holomua a ua ʻike ʻia kahi noiʻi mua i ka regression nui o Cervical Intra-epithelial Neoplasia (CIN) i nā maʻi i mālama ʻia me I3C. Eia nō naʻe, pono nā haʻawina i wehewehe maikaʻi ʻia e hōʻoia i ka hopena chemoprevention a me nā hopena anti-tumor o Indole-3-Carbinol (I3C) a me kāna metabolite Diindolylmethane (DIM) i ka maʻi maʻi umauma, no ka mea hiki ke hoʻopili ʻo DIM me ka maʻamau o ka mālama hormonal therapy. , Tamoxifen. ʻO ka ʻai ʻana i ka meaʻai i loaʻa i ka indole-3-carbinol (I3C) nā meaʻai momona e like me nā lau cruciferous hiki ke makemake ʻia no ka hōʻemi ʻana. Ka maʻi 'aʻai pilikia, ma mua o ka ʻai ʻole ʻana i kēia mau mea hoʻohui, ke ʻole i ʻōlelo ʻia me nā wehewehe ʻepekema.



Indole-3-Carbinol (I3C) a me kāna kumuwaiwai meaʻai

ʻO ka papaʻai momona i nā mea kanu kolio ka mea i manaʻo ʻia he momona a olakino hoʻi. Kākoʻo nā noiʻi nānā ʻokoʻa i ka hiki o kēia mau lauʻai i ka hōʻemi ʻana i ka makaʻu o nā ʻano maʻi ʻaʻai.

nā pono kōkua o indole 3 carbinol I3C ma ke ʻano he mālama mālama i ka maʻi ʻaʻai a no neoplasia intra ʻehaʻeha cervical

ʻO Indole-3-carbinol (I3C) kahi hui i hana ʻia mai kahi mea i kapa ʻia ʻo glucobrassicin, i ʻike pinepine ʻia i nā mea kanu kolio e like me:

  • broccoli 
  • Palukela kupu
  • cabbage
  • kapeluʻala
  • Kale
  • bok choy
  • kohlrabi
  • ʻuala
  • arugula
  • nā turnips
  • nā gela liʻiliʻi
  • nā lālā
  • kahawai wai
  • wasabi
  • mustard 
  • rutabaga

Hoʻokumu pinepine ʻia ʻo Indole-3-carbinol (I3C) i ka wā e ʻoki ʻia, ʻai ʻia a kuke ʻia ai paha nā mea kanu kolio. ʻO ke kumu, ʻoki, ʻokiʻoki ʻana, a nau ʻana a kuke ʻana paha i kēia mau mea kanu i mea hōʻino i nā hunaola mea kanu e ʻae ana i ka glucobrassicin e launa me kahi enzyme i kapa ʻia myrosinase e hopena ana i kāna hydrolysis i indole-3-carbinol (I3C), glucose a me thiocyanate. Lawe ʻia ka 350 mg a 500 mg o Indole-3-carbinol (I3C) e like paha me ka ʻai ʻana ma kahi o 300 gram i 500 gram o ka cabbage maka a i ʻole Brussels sprouts. 

Hiki iā I3C ke hoʻonāukiuki i nā enzyme detoxifying i loko o ka ʻōpū a me ke ake. 

Indable-3-carbinol (I3C) kūpaʻa loa i ka waikawa ʻōpū a no laila ua hoʻohua ʻia i kahi dimer biologically- i kapa ʻia ʻo Diindolylmethane (DIM). Hoʻokomo ʻia ka DIM, ka huahana condensation o Indole-3-carbinol (I3C) mai ka ʻōpū liʻiliʻi.

Nā pono olakino o Indole-3-Carbinol (I3C)

  • ʻO ka hapa nui o ka anti-cancer, anti-inflammatory, antioxidant a me anti-estrogenic o nā mea kanu kolio hiki ke hāʻawi ʻia i indole-3-carbinol (I3C) a me sulforaphane. 
  • Hōʻike nā mea he nui i loko o vitro a me in vivo i nā pono chemopreventive o indole-3-carbinol (I3C) i nā maʻi ʻino e like me ka maʻi māmā, kolona, ​​prostate, a me nā maʻi maʻi umauma a hoʻonui paha i ka hana o kekahi lāʻau chemotherapy. Eia nō naʻe, i kēia manawa, ʻaʻohe hoʻokolohua hoʻokolohua kanaka i hōʻoia i kona hopena ma nā maʻi ʻaʻai. 
  • Hōʻike kekahi mau haʻawina hoʻokolohua / lab e hōʻike nei i nā pono Indole-3-carbinol (I3C) kūpono i nā hana pale a me nā hana antiviral, eia nō naʻe, nele i ka ʻike kanaka ma kēia mua.
  • Hoʻohana pū kekahi i ka I3C e mālama i ka ʻōnaehana lupus erythematosus (SLE), fibromyalgia a me nā papillomatosis hanu hou (laryngeal), eia nō naʻe, ʻaʻohe ʻike ʻepekema maikaʻi e kākoʻo i kēia mau hoʻohana.

Lawe ʻia ʻo Indole-3-Carbinol (I3C) i nā meaʻai momona e like me nā mea kanu kolio e manaʻo ʻia he nui nā pono olakino. Ma waho o kēia mau Indole-3-Carbinol (I3C) mau meaʻai momona, loaʻa pū kekahi nā mea hoʻohui Indole-3-carbinol i ka mākeke i manaʻo ʻia he palekana e lawe i nā nui kūpono ʻaʻole ʻoi aku i ka 400 mg i kēlā me kēia lā. I kekahi poʻe, hiki iā ia ke kumu i kekahi mau hopena e like me ka huehue o ka ʻili a me ka diarrhea. Eia nō naʻe, e hōʻalo i ka lawe nui ʻana a i ʻole nā ​​kiʻekiʻena kiʻekiʻe o I3C no ka mea he kumu ia i nā hopena ʻaoʻao e like me nā pilikia kaulike, ka haʻalulu, a me ka nausea.

E ʻoluʻolu hoʻi e hoʻomaopopo he kakaikahi nā haʻawina holoholona i hōʻike ʻia e hoʻoulu paha ka ulu ulu ʻo I3C. No laila, koi ʻia nā noiʻi e loiloi i ka hopena o indole-3-carbinol (I3C) nā meaʻai momona a me nā mea hoʻohui i nā kānaka. No nā pono olakino laulā, ʻoi aku ka nui o nā meaʻai momona Indole-3-carbinol ma mua o nā mea hoʻopili I3C.

Nā Mea ʻai e ʻAi ai Ma hope o ka ʻike maʻi ʻaʻai!

ʻAʻohe ʻelua maʻi ʻaʻai. E hele i waho o nā kulekele meaʻai maʻamau no kēlā me kēia kanaka a hoʻoholo i nā koho pilikino e pili ana i ka meaʻai a me nā mea hoʻopihapiha me ka hilinaʻi.

Hoʻohana o Indole-3-carbinol (I3C) i ka maʻi ʻaʻai

Kākoʻo nā haʻawina nānā ʻokoʻa a me nā papaʻaiʻai i ka hui ma waena kaʻai kiʻekiʻe kiʻekiʻe o nā mea kanu kolio a hoʻoliʻiliʻi i nā maʻi ʻaʻai. ʻO kēia hopena chemo-preventive o kēia mau indole-3-carbinol (I3C) mau mea waiwai i loaʻa i ka antitumor activity o I3C a me kāna metabolite Diindolylmethane (DIM), a me sulforaphane. Eia nō naʻe, ʻaʻole nui nā noiʻi i loiloi i ka hui ma waena o indole-3-carbinol (I3C) a me ka maka maʻi ʻaʻai. Ma lalo, ua hoʻolako mākou i nā kikoʻī o kekahi o nā noiʻi e pili ana i ka I3C a me ka maʻi ʻaʻai.

Nā pōmaikaʻi o Indole-3-carbinol (I3C) a me Epigallocatechin gallate (EGCG) i nā mea maʻi maʻi maʻi ʻōpio holomua.

Ma ke ao holoʻokoʻa, ʻo ka maʻi ʻaʻai ovarian ka walu o ka maʻi ʻaʻai e ʻike pinepine ʻia i nā wahine a me ka 18th ʻike pinepine ʻia i ka maʻi ʻaʻai, me ka 300,000 mau hihia hou i ka makahiki 2018. (Kālā ʻImi ʻImi Honua Honua) Ma kahi o 1.2 pākēneka o nā wahine e ʻike ʻia me ka maʻi ʻaʻai ovarian i kekahi manawa i ko lākou ola. (SEER., Cancer Stat Facts, National Cancer Institute) ʻOiai ua hoʻomaikaʻi ke ola o 5 mau makahiki no ka maʻi ʻaʻai ovarian i nā makahiki 30 i hala iho nei, ma ke ʻano holoʻokoʻa, mau nō ka maikaʻi o ka wānana no ka maʻi ʻaʻai ovarian, me ka lōkahi o ka helu o ke ola 5 mau makahiki ma waena o 12-42% no nā maʻi ʻaʻai ovarian holomua. 60-80% o kēia mau maʻi i mālama ʻia me ka maʻamau o ka mālama ʻana i nā chemotherapies e hoʻi hou ana i 6 a 24 mau mahina e hopena ana i ka pono no ka chemotherapy hou aku, a laila hiki ke pale ʻia ka tumo chemo.

No laila, nā mea noiʻi mai ka University People's Friendship University o Russia, Russian Scientific Center of Roentgenoradiology (RSCRR) a me MiraxBioPharma ma Lūkia a me Wayne State University ma ka US i hana i kahi hoʻokolohua hoʻokolohua hoʻokolohua e loiloi i ka pono o ka mālama mālama wā lōʻihi me indole-3 -carbinol (I3C), a me kahi mālama mālama me indole-3-carbinol (I3C) a me epigallocatechin-3-gallate (EGCG) i nā mea maʻi maʻi ʻaʻa ovarian holomua. ʻO Epigallocatechin gallate (EGCG) kahi mea hana nui i loko o ke kī ʻōmaʻomaʻo me nā anti-inflammatory a me nā antioksidant waiwai. (ʻO Vsevolod I Kiselev et al, BMC maʻi ʻaʻai., 2018)

Ua komo ka hoʻopaʻa ʻana ma RSCRR i nā hui he 5 (e like me ka mea i wehewehe ʻia ma lalo) o nā wahine he 284 he mau makahiki ≥ 39 mau makahiki me nā maʻi ʻehā ovarian serous pae III-IV, i kākau inoa ʻia ma waena o Ianuali 2004 a me Kekemapa 2009, i loaʻa i nā lāʻau lapaʻau hui pū me neoadjuvant platinum-taxane chemotherapy, ʻoki kino, a me adjuvant platinum-taxane chemotherapy. 

  • Ua loaʻa i ka hui 1 ka hoʻohuihui hoʻohui ʻia me I3C
  • Ua loaʻa i ka hui 2 ka hoʻomaʻamaʻa hoʻohui ʻia me I3C a me Epigallocatechin gallate (EGCG)
  • Ua loaʻa i ka hui 3 ka lapaʻau hui pū ʻia me I3C a me Epigallocatechin gallate (EGCG) a me chemotherapy platinum-taxane lōʻihi lōʻihi.
  • Mālama ka hui 4 i ka hoʻomaʻamaʻa hoʻokahi ʻana me ka neoadjuvant platinum-taxane chemotherapy
  • Mālama i ka hui 5 i hui pū ʻia me ka mālama ʻana

Eia aʻe nā mea nui i loaʻa i ke aʻo ʻana.

  • Ma hope o ka ukali ʻana o ʻelima mau makahiki, ʻo nā wahine i loaʻa ka mālama mālama me indole-3-carbinol, a i ʻole I3C me Epigallocatechin gallate (EGCG), ua hoʻolōʻihi ʻia kahi Progressive Free Survival a me ke ola holoʻokoʻa i hoʻohālikelike ʻia me nā wahine i nā pūʻulu hoʻomalu. 
  • ʻO Median Over Survival he 60.0 mau mahina ma ka Pūʻulu 1, 60.0 mau mahina i nā Pūʻulu 2 a me 3 i loaʻa ka mālama mālama ʻoiai 46.0 mau mahina ma ka Pūʻulu 4, a me 44.0 mau mahina ma ka Pūʻulu 5. 
  • ʻO ka Median Progression Free Survival he 39.5 mau mahina ma ka Pūʻulu 1, 42.5 mau mahina i ka Pūʻulu 2, 48.5 mau mahina i ka Pūʻulu 3, 24.5 mau mahina i ka Pūʻulu 4, 22.0 mau mahina i ka Pūʻulu 5. 
  • ʻO ka helu o nā mea maʻi me ka maʻi ʻaʻai ovarian hou me nā ascites ma hope o ka hoʻowalewale ʻia ʻana ua hoʻoliʻiliʻi nui ʻia i nā hui i loaʻa ka mālama mālama me indole-3-carbinol a I3C paha me Epigallocatechin gallate (EGCG), hoʻohālikelike ʻia i nā pūʻulu kaohi.

Ua hoʻoholo nā kānaka noiʻi ʻo ka hoʻohana wā lōʻihi o indole-3-carbinol (I3C) a me Epigallocatechin gallate (EGCG) hiki ke hoʻomaikaʻi i nā hopena lapaʻau (e pili ana i 73.4% hoʻomaikaʻi e like me ka mea i ʻike ʻia i loko o ka noiʻi) i nā maʻi maʻi ʻaʻai ovarian holomua a hiki ke lilo i mālama mālama. kaukaʻi no kēia mau maʻi.

Nā pono o Indole-3-carbinol (I3C) i nā mea maʻi me ka Cervical Intra-epithelial Neoplasia (CIN)

ʻO Ceropal Intra-epithelial Neoplasia (CIN) a i ʻole Cerplic dysplasia kahi kūlana precancerous kahi e ulu ai nā ulu o ke kino ma ka ʻili o ka cervix a i ʻole ke kahawai endocervical ʻo ia ka wehe ma waena o ka pūpū a me ka ʻōpū. Mālama pinepine ʻia ʻo Cervical Intra-epithelial Neoplasia me ke kahakaha a i ʻole ka ablative therapy e hōʻino ai i ka nāʻaʻa ʻino. 

Ma mua o ka mālama ʻana i ka maʻi ʻaʻai cerviery ma hope o ka maʻi ʻaʻai, ʻoi aku ka maikaʻi o ka ʻike ʻia ma ke kaʻina mua a i ʻole ke kaʻina precancerous a komo i ka wā ma mua me ka hoʻohana ʻana i nā synthetic a i ʻole nā ​​mea kūlohelohe e like me indole-3-carbinol (I3C) a pale i ka hoʻomohala ʻana o ka maʻi hoʻoweliweli. Me kēia i ka noʻonoʻo, nā mea noiʻi mai ka Louisiana State University Medical Center-Shreveport ma United States, loiloi ʻia indole-3-carbinol (I3C) i lawelawe waha ʻia e mālama i nā wahine me Ceropal Intra-epithelial Neoplasia (CIN), ma ke ʻano he therapeutic no CIN . (MC Bell et al, Gynecol Oncol., 2000)

Loaʻa i loko o ka noiʻi he 30 mau maʻi i loaʻa i ka placebo a i ʻole 200, a i ʻole 400 mg / lā o ka indole-3-carbinol oral (I3C). 

Ma hope nā ʻike nui o ke aʻo ʻana.

  • Mai loko mai o nā maʻi he 10 i ka hui i loaʻa kahi placebo, ʻaʻohe mea i hoʻopau hou i ka Cervical Intra-epithelial Neoplasia (CIN). 
  • 4 o nā maʻi 8 ma ka hui i loaʻa iā 200 mg / lā o ka indole-3-carbinol oral (I3C) i piha piha i ka Cervical Intra-epithelial Neoplasia (CIN). 
  • 4 o nā maʻi 9 ma ka hui i loaʻa iā 400 mg / lā o ka indole-3-carbinol oral (I3C) i piha piha i ka Cervical Intra-epithelial Neoplasia (CIN). 

I ka pōkole, ua loaʻa i nā mea noiʻi ka hoʻoliʻiliʻi koʻikoʻi o Cervical Intra-epithelial Neoplasia (CIN) i nā maʻi i mālama ʻia me indole-3-carbinol (I3C) i hoʻohālikelike waha ʻia me ka poʻe i loaʻa kahi placebo. 

ʻO Chemoprevention Potential o Indole-3-Carbinol (I3C) i ka maʻi ʻaʻai umauma

Wahi a kekahi pepa i paʻi ʻia ma ka makahiki 1997 e nā kānaka noiʻi mai ka Strang Cancer Prevent Center ma New York, United States, he 60 mau wahine i hoʻonui i ka makaʻu no ka maʻi ʻaʻai umauma i kākau inoa ʻia i loko o kahi hoʻokolokolo i kāohi ʻia e kahi placebo e loiloi i ka hiki chemoprevention o I3C. Ma loko o kēia mau mea, he 57 mau wahine me ka makahiki o 47 mau makahiki i pau i ke aʻo ʻana. (GY Won et al, J Cell Biochem Suppl., 1997)

Hoʻokomo ʻia kēia mau wahine i loko o kekahi o nā hui 3 (kikoʻī ma lalo) i loaʻa i kahi placebo capsule a i ʻole indole-3-carbinol (I3C) capsule i kēlā me kēia lā no ka nui o 4 mau pule. 

  • Ua loaʻa i ka hui kāohi ka Placebo capsule
  • Loaʻa i ka hui haʻahaʻa ka 50, 100, a me 200 mg o I3C
  • Loaʻa i ka hui dosis kiʻekiʻe 300 a me 400 mg o I3C

ʻO ke kiko hope loa i hoʻohana ʻia i kēia noi ʻana ka lakio metabolite urinary estrogen o 2-hydroxyestrone i 16 alpha-hydroxyestrone.

Ua ʻike ʻia ka noiʻi ʻana o ka loli pili piko o ka hopena hopena no nā wahine i ka hui o nā lāʻau kiʻekiʻe i ʻoi aku ka kiʻekiʻe ma mua o kēlā me nā wahine i ka kaohi a me nā pūʻulu haʻahaʻa ma o ka nui i pili i ka lakio palena.

Ua hōʻike pū ʻia nā ʻike mai ka noiʻi ʻana ʻo indole-3-carbinol (I3C) ma ka liʻiliʻi loa o ka papa kuhikuhi o 300 mg i kēlā me kēia lā he mea hoʻohiki no ka pale ʻana i ka maʻi maʻi umauma. Eia nō naʻe, ʻoi aku ka nui o nā haʻawina hoʻomaʻamaʻa i wehewehe pono ʻia e hōʻoia i kēia mau ʻike a hiki mai me ka hopena maikaʻi loa o I3C no ka umauma lōʻihi. Ka maʻi 'aʻai hoʻopaʻa kino.

ʻO Diindolylmethane i ka maʻi ʻaʻai umauma i nā maʻi e lawe iā Tamoxifen

Ma muli o ka hiki chemopreventive hiki ke loaʻa i nā mea kanu kolio a me nā hopena anti-tumole o Indole-3-carbinol (I3C) i ka maʻi ʻaʻai umauma, ua hoihoi ka nānā ʻana inā ʻo Diindolylmethane, ka metabolite mua o Indole-3-carbinol (I3C), nā pōmaikaʻi i ka maʻi ʻaʻai umauma. (Cynthia A Thomson et al, Breast Cancer Res Hana, 2017)

Ua hana nā mea noiʻi mai ke Kulanui o Arizona, University of Arizona Cancer Center, Stony Brook University a me University of Hawaii Cancer Center ma ʻAmelika Hui Pū ʻIa i kahi hoʻokolohua lapaʻau e loiloi i ka hana a me ka palekana o ka hoʻohana ʻana o Diindolylmethane (DIM) me Tamoxifen ma ka umauma Ka maʻi 'aʻai maʻi.

ʻO 98 mau wahine me ka maʻi ʻaʻai umauma i kuhikuhi ʻia me tamoxifen i loaʻa iā DIM (47 mau wahine) a i ʻole placebo (51 mau wahine). Ua ʻike ʻia ka noiʻi ʻana i kēlā me kēia lā DIM e hoʻoholomua i nā loli maikaʻi i ka estrogen metabolism a me nā pae kahe o ka sex-binding globulin (SHBG). Eia nō naʻe, ua hoʻemi ʻia nā pae o ka plasma tamoxifen metabolite e laʻa me endoxifen, 4-OH tamoxifen, a me N-desmethyl-tamoxifen i nā wahine i loaʻa iā DIM, e ʻōlelo ana e loaʻa paha i ka DIM ka hiki ke hoʻemi i ka pono o Tamoxifen. (NCT01391689).  

Pono ʻia kahi noiʻi hou e hoʻoholo inā ʻo DIM (ka huahana condence o Indole-3-Carbinol (I3C)) pili i ka hoʻoliʻiliʻi o nā metabolites tamoxifen e like me endoxifen, hoʻonāuki i ka pono o ka tamoxifen. A hiki i kēlā manawa, ʻoiai ke hōʻike nei ka ʻikepili hoʻokolohua i kahi loli o ka pilina ma waena o DIM a me ka tamoxifen hormonal therapy, nā mea maʻi maʻi umauma ʻoiai ʻo tamoxifen therapy e pono e ʻaoʻao ma ka ʻaoʻao akahele a pale i ka lawe ʻana i ka waihona DIM.

Maikaʻi nā mea kanu Cruciferous no ka maʻi ʻaʻai? | Hoʻolālā Diet pilikino pilikino i hōʻoia

Panina

Loaʻa paha nā Indole-3-carbinol (I3C) i nā anti-tumor pono e like me ka mea i ʻōlelo ʻia e ka in vitro mua, in vivo a me nā holoholona a me nā kuhiakau e pili ana i nā noiʻi observational i hōʻike i ka ʻai nui ʻana o nā mea kanu kolio i loko o ka papaʻai. kahi hōʻemi hoʻemi ʻia o nā maʻi ʻaʻai. Eia nō naʻe, ʻaʻole nui nā noiʻi i loko o nā kānaka e hoʻokumu i kēia mau ʻike. 

Ua ʻike ʻia kahi noiʻi hou ma 2018 e loaʻa i ka hoʻohana lōʻihi o indole-3-carbinol (I3C) nā pōmaikaʻi ma ke ʻano he mālama mālama a me ka hoʻomaikaʻi ʻana i nā hopena o ka mālama ʻana i nā maʻi maʻi maʻi ovarian holomua a ua ʻike ʻia kahi noiʻi mua i ka regression nui o Cervical Intra-epithelial. Neoplasia (CIN) i nā maʻi i mālama ʻia me I3C. Eia nō naʻe, pono nā haʻawina i wehewehe maikaʻi ʻia e hōʻoia i ka hopena chemoprevention a me nā hopena anti-tumor o Indole-3-Carbinol (I3C) a me kāna metabolite Diindolylmethane (DIM) i ka umauma. Ka maʻi 'aʻai, no ka mea, hiki i ka DIM ke launa pū me ka maʻamau o ka mālama ʻana i ka hormonal therapy tamoxifen a hoʻemi i nā pae o kona ʻano hana endoxifen, e hoʻopilikia paha i ka hopena therapeutic o tamoxifen. No laila, ʻoi aku ka maikaʻi o ka ʻai ʻana i nā meaʻai e like me nā mea kanu cruciferous i loaʻa i ka Indole-3-Carbinol (I3C), ma mua o nā mea hoʻohui, ke ʻole i ʻōlelo ʻia e kāu mea mālama ola.

He aha nā meaʻai āu e ʻai ai a me nā mea hoʻopihapiha āu e lawe ai i hoʻoholo. Pono e hoʻoholo i kāu hoʻoholo ʻana e pili ana i ka hoʻololi ʻana i nā ʻāpana o ka maʻi ʻaʻai, ka maʻi ʻaʻai, nā lāʻau e hoʻomau nei a me nā mea hoʻopihapiha, nā maʻi āpau, nā ʻike nohona, ke kaupaona, ke kiʻekiʻe a me nā ʻano.

ʻAʻole hoʻokumu ʻia ka hoʻolālā meaʻai no ka maʻi ʻaʻai mai addon ma ka ʻimi pūnaewele. Hoʻokele ia i ka hoʻoholo ʻana iā ʻoe ma muli o ka ʻepekema molekole i hoʻokō ʻia e ko mākou ʻepekema a me nā ʻenekini polokalamu. Nānā ʻole inā ʻoe e noʻonoʻo e hoʻomaopopo i ke ʻano o nā ʻolaola biōmika kumu a i ʻole ʻole - no ka hoʻolālā meaʻai no ka maʻi ʻaʻai e pono ai ka ʻike.

E hoʻomaka I K NOWIA manawa me kāu hoʻolālā meaʻai e ka pane ʻana i nā nīnau e pili ana i ka inoa o ka maʻi ʻaʻai, ka hoʻololi ʻana o nā kūpuna, nā mālama ʻana a me nā mea hoʻopihapiha mau, nā maʻi āpau, nā ʻano, ka nohona, nā makahiki a me nā kāne.

hōʻike hōʻike

Mea 'ai pilikino no ka ma'i 'a'ai!

Hoʻololi ka maʻi kanesa me ka manawa. Hoʻopilikino a hoʻololi i kāu meaʻai e pili ana i ka hōʻailona maʻi maʻi, ka mālama ʻana, ke ʻano o ka nohona, nā makemake meaʻai, nā allergies a me nā mea ʻē aʻe.


ʻO nā mea maʻi maʻi maʻi e hana pinepine me nā mea ʻokoʻa nā hopena ʻaoʻao chemotherapy kahi e hoʻopili ai i ko lākou ola o ke ola a nānā i nā hoʻoponopono ʻokoʻa no ka maʻi ʻaʻai. Lawe ana i ka ka meaʻai kūpono a me nā mea hoʻopihapiha e pili ana i nā noʻonoʻo ʻepekema (ka hōʻalo ʻana i ka wānana a me ke koho wale ʻana) ʻo ia ka lāʻau kūlohelohe maikaʻi loa no ka maʻi ʻaʻai a me nā lāʻau e pili ana i nā hopena ʻaoʻao.


Nānā ʻepekema e: Kauka Cogle

ʻO Christopher R. Cogle, MD he polopeka paʻa ma ke Kulanui o Florida, Luna Lapaʻau Nui o Florida Medicaid, a me Luna Hoʻokele o ka Florida Health Policy Leadership Academy ma ka Bob Graham Center for Public Service.

Hiki iā ʻoe ke heluhelu i kēia ma

Pehea ka waiwai o kēia kūlana?

Kaomi ma ka hōkū no ke kohoʻana!

Pane pālākio waena 4.7 / 5. Helu helu: 67

ʻAʻole i koho balota a hiki i kēia wā. ʻO ia ka mea e helu i kēia pou

Loaʻa iāʻoe kēia kūlana kūpono ...

E hahai iā mākou ma ka pāʻina kaiaulu!

Ke mihi nei mākou no ka ponoʻole o kēia pou iāʻoe!

E hoʻonui kākou i kēia kūlana!

E haʻi mai iā mākou pehea mākou e hoʻonui ai i kēia pou?